QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)

Protara Therapeutics (TARA) News Today

$2.62
-0.13 (-4.73%)
(As of 03:58 PM ET)
SourceHeadline
msn.com logoProtara Therapeutics (TARA) Price Target Decreased by 11.76% to 27.54
msn.com - April 17 at 12:11 PM
finance.yahoo.com logoProtara Therapeutics, Inc. (TARA)
finance.yahoo.com - April 15 at 6:45 PM
MarketBeat logoProtara Therapeutics (NASDAQ:TARA) Stock Rating Reaffirmed by HC Wainwright
americanbankingnews.com - April 9 at 3:46 AM
markets.businessinsider.com logoBuy Rating for Protara Therapeutics’ TARA-002 Based on Promising Clinical Data and Market Potential in NMIBC Treatment
markets.businessinsider.com - April 9 at 2:25 AM
msn.com logoProtara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
msn.com - April 5 at 3:10 PM
markets.businessinsider.com logoProtara Reaches Alignment With FDA On A Registrational Path Forward For IV Choline Chloride
markets.businessinsider.com - April 5 at 10:10 AM
markets.businessinsider.com logoProtara Announces Positive Data From TARA-002 Trial In Bladder Cancer; Stock Up
markets.businessinsider.com - April 5 at 10:10 AM
globenewswire.com logoProtara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
globenewswire.com - April 5 at 8:04 AM
globenewswire.com logoProtara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
globenewswire.com - April 5 at 8:02 AM
globenewswire.com logoProtara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
globenewswire.com - April 5 at 8:00 AM
investorplace.com logo3 Stocks That Could Help You Retire on a Private Island
investorplace.com - March 23 at 6:00 AM
markets.businessinsider.com logoBuy Rating on Protara Therapeutics Backed by Promising TARA-002 Clinical Trials and Significant Market Opportunity
markets.businessinsider.com - March 13 at 6:27 PM
chron.com logoProtara Therapeutics: Q4 Earnings Snapshot
chron.com - March 13 at 1:26 PM
globenewswire.com logoProtara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
globenewswire.com - March 13 at 8:00 AM
finance.yahoo.com logoTARA Aug 2024 7.500 call
finance.yahoo.com - March 3 at 11:42 PM
finance.yahoo.com logoTARA May 2024 2.500 put
finance.yahoo.com - March 3 at 11:42 PM
marketbeat.com logoProtara Therapeutics, Inc. (NASDAQ:TARA) Sees Large Decline in Short Interest
marketbeat.com - March 1 at 1:38 PM
theglobeandmail.com logoNon Muscle Invasive Bladder Cancer Pipeline Outlook Report 2024
theglobeandmail.com - February 28 at 7:58 PM
globenewswire.com logoProtara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
globenewswire.com - February 28 at 8:00 AM
msn.com logoNorthSea Therapeutics commences Phase IIa trial for IFALD therapy
msn.com - February 22 at 7:53 PM
finance.yahoo.com logoWe're Keeping An Eye On Protara Therapeutics' (NASDAQ:TARA) Cash Burn Rate
finance.yahoo.com - February 17 at 8:43 AM
seekingalpha.com logoCG Oncology's Lead Bladder Cancer Drug Offers A Strong Potential Revenue Stream With Buyout Optionality
seekingalpha.com - January 25 at 3:04 PM
markets.businessinsider.com logoOppenheimer Reaffirms Their Buy Rating on Protara Therapeutics (TARA)
markets.businessinsider.com - December 2 at 7:37 PM
finance.yahoo.com logoProtara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
finance.yahoo.com - November 30 at 12:38 PM
benzinga.com logoProtara Therapeutics Stock (NASDAQ:TARA) Earnings Dates and Earning Calls
benzinga.com - November 5 at 1:52 PM
msn.com logoProtara Therapeutics reports Q3 results
msn.com - November 5 at 12:01 AM
msn.com logoProtara Therapeutics files for $300M mixed shelf
msn.com - November 3 at 2:21 PM
finance.yahoo.com logoProtara Therapeutics Inc (TARA) Announces Q3 2023 Financial Results
finance.yahoo.com - November 3 at 2:21 PM
finance.yahoo.com logoProtara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
finance.yahoo.com - November 3 at 9:20 AM
msn.com logoProtara begins dosing in Phase II lymphatic malformation cell therapy trial
msn.com - October 24 at 5:04 AM
finance.yahoo.com logoProtara Therapeutics Announces Dosing of First Patient in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
finance.yahoo.com - October 23 at 9:02 AM
benzinga.com logoNon Muscle Invasive Bladder Cancer Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)
benzinga.com - October 7 at 1:33 AM
finance.yahoo.com logoHere's Why We're Watching Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation
finance.yahoo.com - September 10 at 5:44 PM
finance.yahoo.com logoProtara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - September 5 at 5:44 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Their Buy Rating for Protara Therapeutics (TARA)
markets.businessinsider.com - August 4 at 7:41 PM
msn.com logoHC Wainwright & Co. Reiterates Protara Therapeutics (TARA) Buy Recommendation
msn.com - August 4 at 7:41 PM
msn.com logoProtara Therapeutics (TARA) Price Target Decreased by 6.96% to 32.03
msn.com - August 3 at 4:59 PM
finance.yahoo.com logoProtara Therapeutics Announces Second Quarter 2023 Financial Results and Business Update
finance.yahoo.com - August 3 at 11:58 AM
finance.yahoo.com logoTARA - Protara Therapeutics, Inc.
finance.yahoo.com - July 14 at 3:40 PM
finance.yahoo.com logoUS74365U1079.SG - Protara Therapeutics Inc.
finance.yahoo.com - June 11 at 5:25 PM
markets.businessinsider.com logoH.C. Wainwright Remains a Buy on Kamada (KMDA)
markets.businessinsider.com - May 25 at 7:47 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Their Buy Rating for Bellerophon (BLPH)
markets.businessinsider.com - May 17 at 10:05 AM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Keros Therapeutics (KROS)
markets.businessinsider.com - May 8 at 7:15 AM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Veru (VERU), Viking Therapeutics (VKTX)
markets.businessinsider.com - May 8 at 7:15 AM
msn.com logoRecap: Protara Therapeutics Q1 Earnings
msn.com - May 4 at 3:10 PM
finance.yahoo.com logoProtara Therapeutics Announces First Quarter 2023 Financial Results and Business Update
finance.yahoo.com - May 4 at 10:09 AM
finance.yahoo.com logoProtara Therapeutics Receives Regulatory Clearance from FDA to Commence Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
finance.yahoo.com - May 2 at 9:24 AM
msn.com logoHC Wainwright & Co. Reiterates ArTara Therapeutics (TARA) Buy Recommendation
msn.com - May 1 at 9:19 AM
msn.com logoProtara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer
msn.com - April 28 at 1:56 PM
finance.yahoo.com logoProtara Therapeutics Announces Positive Preliminary Data from ADVANCED-1 Phase 1a Dose Escalation Trial of TARA-002 in NMIBC Supporting Advancement into Phase 2 Clinical Development
finance.yahoo.com - April 28 at 8:55 AM
Get Protara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TARA and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

TARA Media Mentions By Week

TARA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TARA
News Sentiment

0.33

0.52

Average
Medical
News Sentiment

TARA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TARA Articles
This Week

2

0

TARA Articles
Average Week

Get Protara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TARA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TARA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners